62
Participants
Start Date
January 4, 2017
Primary Completion Date
February 7, 2023
Study Completion Date
February 5, 2024
pembrolizumab
anti PD-1
The Christie NHS Foundation Trust, Manchester
Southampton University Hospitals NHS Trust, Southampton
Maidstone and Tunbridge Wells NHS Trust, Maidstone
University Hospital Birmingham NHS Foundation Trust, Birmingham
Velindre Cancer Centre, Cardiff
Western General Hospital, Edinburgh
United Lincolnshire Hospitals NHS Trust, Lincoln
Barts Health NHS Trust, London
University College London Hospitals, London
The Royal Marsden Hospital, London
Merck Sharp & Dohme LLC
INDUSTRY
University of Birmingham
OTHER